1March 2017

Providing sustainable solutions for increasing crop quality and yield

2

>30x Revenue

Solution:We have developed a patent pending, globally scalable, OMRI certified, shelf stable, multi-consortia microbial soil

additive that significantly increases crop yields

Problem:

Increasing crop yields more sustainably –

achieving higher yield per unit input

at least a 10:1 ROI to producers!

Increased Plant Yield!

> 30% increased yield

45% increased yield

MAMMOTH P® is an organically derived microbial inoculant

specifically designed to maximize plant yield across many crops!

Increased Plant Nutrient Uptake!

MAMMOTH P® acts as a catalyst to maximize yield

across many specialty crops and traditional row crops

6

screened millions of soil bacteria

high throughput functional selection

improves plant phosphorus uptake

Our Platform Technology

We Develop Very Effective Products

novel selection platform

rapid development

extremely effective

globally scalable

exceptional shelf stability

LOW

Effectiveness

H IGH

Co

nve

nie

nce

LO

W

HIG

H

compatible with all products

very easy to use

reliably increases yield

MAMMOTH P® Works with all Fertilizer Products

Faster growth!

*

Tomato Productivity

Mammoth P

Control

Yie

ld (

g)

0

100

200

300

400

500

600

>30% increasedyield

> 10:1 ROI to producers

45% increasedyield

Strawberry Yield

Days since planting

129 161 175 198 213

Yie

ld (

lb a

cre

-1)

0

500

1000

1500

2000

2500

3000

Control

Mammoth P

Increases Yield Across Many Crops!

10

Crop ($ / km2)

Strawberries $9.30 M

Tomatoes $1.76 M

Grapes $1.39 M

Rice $0.24 M

Maize $0.14 M

Soybeans $0.10 M

Wheat $0.04 M

Legal Cannabis $47.7 M

sources: United Nations, FAQ, UNODCdata: bit.ly/KIB_CashCropsTo

tal R

eve

nu

e

Area Planted

Tea

Strawberries

Tomatoes

Rice

Maize

WheatSoybeans

Sugarcane

Potatoes

Beans

Tobacco

Sugar beet

Coffee

Palm

Cassava

Rapeseed

Barley

Grapes

Vegetables

Cannabis

Cannabis is the most lucrative

Validated Most Lucrative Market Opportunity

$100B Market by 2029 with 50M Consumers

Ackrell Capital: “U.S. Cannabis Investment Report 2016”

A Huge Opportunity

assumed end of Federal Prohibition

13

2015

FYE

1st Q

TR 2

016

2nd

QTR

201

6

3rd

QTR

201

6

4th

QTR

201

6

1st Q

TR (2

017)

$700,000

$500,000

$300,000

$100,000 $58K

$172K

$248K

$462K

$648K

$714K

*2017 (actual) > $725K

*

= cash flow positive

Revenue is Exceeding Expectations

• Dynamic

• Sales Team

We have a well established distribution channel

Direct Sales > 400 retail store

partners!

Elite Sales Teamsales executives and

support staff

E- commercedozens of web based

online partners

We are Making Headlines!

Steve Blank.com

Accomplished Key Milestones

03/2014 Initial R & D

04/2015$450,000 Seed

08/2015First Revenue

05/2016$1.0M Bridge

FYE 2016 >$1.5M Revenue (Cash- Positive)

2017Scale Team

New Products

Market Expansion

Exceptional Cofounders and Executive Team

Leading PhD Soil Microbiologists

Driving Sustainable Technology to Enhance Plant Yields

Seasoned Executive Leadership

Matt Wallenstein, Ph.D. Co-founder

Rich Conant, Ph.D.Co-founder

Colin Bell, Ph.D.Co-founder and Chief Growth Officer

Gregg SteinbergCEO

Globally Distinguished Group of Working Advisors

Matt Henn, Ph.D.bioinformatics, recent IPO

Andy Renz, Ph.D.BASF Plant Science, now entrepreneur

Christine PerichCEO of New Belgium Brewing Company

Jack Gilbert, Ph.D.thought leader in microbial ecology

Greg Owsleybranding strategy, Fat Tire -New Belgium Brewing Company

Committed Stakeholders Adding Value Along the Way

Top Tier Venture Capital Partners

Errol Arkilic, Ph.D. Jim Hornthal

Steve Blank Tom Baruch

Aksarben Innovation Initiative

Series A: $5.0M (equity)

We’ve Experienced Significant Growth!

Q3

20

15

Q4

20

15

Q1

20

16

Q2

20

16

Q3

20

16

Q4

20

16

Q1

20

17

Q2

20

17

Q3

20

17

Q4

20

17

Quarterly Revenue

$1,200,000

0

$800,000

$400,000

$1,600,000 $1.47M

$1.11M

$870K

$648K

$462K

$248K

$47K$42K

$172K

$714K

(2017 projected)

$4.2M

= cash flow positive

Looking Forward: Multiple Products and Many Crops

MAMMOTH N TM

Improving N- delivery for plant uptake!

Crop Diversification

scalable to $1B company

synergistic with all products

currently scaling revenue

patent protectable technology

national media exposure

market and product diversity

Join us on our journey!

Contact:Gregg Steinberggregg@growcentia.com970-818-2795

www.growcentia.comwww.mammothmicrobes.com

Summary

Appendix

Growcentia’s cofounders and executive leadership

Colin Bell, Co-founder, co-inventor and Chief Growth Officer at

Growcentia. He completed his Ph.D. at Texas Tech University in

2009 and became a member of the Wallenstein lab in August

2011. His initial research involved working with the

collaborative research team at the prairie heating and elevated

CO2 experimental site (PHACE) in Wyoming. The overall goal of

this project was to characterize the effects of elevated

atmospheric CO2 and increased temperatures on the metabolic

and physiological characteristics of plant and soil microbial

properties associated within plant community rhizospheres in

the mixed grass prairie. His more recent research interests focus

on specific plant species-microbial relationships within the

rhizosphere zone. These ongoing efforts involve several projects

designed to elucidate rhizosphere stoichiometry and plant

rhizoengineering mechanisms that influence soil microbial

taxonomic and functional diversity to promote plant fitness.

Gregg Steinberg is Growcentia’s CEO. He has been involved in

startups to mature companies and from private to public entities.

He has expertise in launching and scaling early stage companies,

executing on valuation creation strategies and in raising seed /

venture capital. He has been an investor and advisor in numerous

companies including retail and commercial CPG product rollouts.

He was President of a company that was listed twice in the top 10

of the INC500 and cumulative revenues under his presidency of

that organization exceeded $2 billion. He is an active member of

Young Presidents Organization (YPO/WPO) and sits on numerous

charitable boards, including the American Committee for the

Weizmann Institute for Science, The Simon School (Univ. of

Rochester) Executive Advisory Board and the Global Institute of

Leadership, Tufts University. He is an EIR at the University of

Rochester and Co-Managing Director of the Simon School Venture

Capital Fund. He received his MBA from the Thunderbird School

of Global Management and BSBA from the Univ. of Arizona.

Gregg SteinbergColin Bell. Ph.D.

Growcentia co-founders and executive leadership

Matt Wallenstein Ph. D is Co-founder, co-inventor and Chairman at

Growcentia. Matt is a globally-recognized expert in how living organisms in

soils help cycle nutrients to support healthy plants with over 70 publications

and many awards including the National Science Foundation CAREER award.

He is an Associate Professor in the Department of Ecosystem Science and

Sustainability and a research scientist at the Natural Resource Ecology

Laboratory. He also directs the Innovation Center for Sustainable Agriculture

and is president of the Soil Ecology Society.

Richard Conant Ph. D is a Co-founder of Growcentia. He is an ecosystem

ecologist at the Natural Resource Ecology Laboratory and an associate

professor in the newly-formed Department of Ecosystem Science and

Sustainability at Colorado State University. He is also affiliated with the

International Livestock Research Institute and Queensland University of

Technology. He is studying how land use and land management practices

impact carbon and nitrogen cycling in agricultural and grassland ecosystems.

Rich is a participant in national and international efforts to quantify human

impacts on carbon cycling and he earned his Ph.D at Arizona State University in

1997.

Richard Conant Ph.D.

Matt Wallenstein Ph.D.

M34 Capital

Tom Baruch, Founder - is the Founder of Formation8 Partners. Tom formed CMEA Capital, an early-stage venture capital fund investing in energy, IT, life science companies, in 1988 with New Enterprise Associates. Earlier in his career, Tom worked at Exxon Mobil for 12 years, eventually leaving as President of the Exxon Materials Division. After Exxon, Tom founded Microwave Technology, Inc. where he served as CEO for 6 years before founding CMEA Capital, a fund with $1.2 billion under management. Currently, Tom serves as Chairman of the Board of Codexis, Inc. (NASDAQ: CDXS) and Intermolecular, Inc. (NASDAQ: IMI). He also currently serves on the boards of CNano Technologies, Foro Energy and Wildcat Discovery Technologies. Tom is a member of Obama’s National Advisory Council on Innovation and Entrepreneurship (NACIE), where he advises the U.S. Department of Commerce and the White House on science and technology innovation, a member of the Executive Committee of the U.S. Council of Competitiveness, and a member of the Steering Committee of its ESIS (Energy, Security, Innovation and Sustainability) Initiative and the U.S. Manufacturing Competitiveness Initiative. He is also a member of the “Brain Trust” of the ARPA-E program within the U.S. Department of Energy. Tom holds a JD from Capital University and a BS degree in Metallurgical Engineering from the Rensselaer Polytechnic Institute.

Errol Arkilic, Founder and CEO. Before co-founding the company, Errol was the founding and lead program director for the NSF I-Corps program. He led the I-Corps effort from its inception until July 2013. Previously, he was the lead software and services Program Director for the NSF SBIR program. Before his government service, Errol was founder and CEO at StrataGent Lifesciences and Manager of Product Engineering at Redwood Microsystems. Errol is also a founder of USRCA, a non-profit that focuses on entrepreneur education for science and engineering graduates. Errol earned a BS in Mechanical Engineering from George Washington University and a Masters and Ph.D. degree in Aero/Astro Engineering from MIT.

Errol Arkilic, Ph.D.Tom Baruch

M34 Capital

Jim Hornthal, Founder and Chairman. Jim is a parallel entrepreneur, angel investor, entrepreneurship educator, and a Lester Center Fellow for Entrepreneurship and Innovation at UC Berkeley Haas School of Business. His private investment fund, Hornthal Investment Partners, has made investments in over 50 early stage companies. Jim is the co-founder and Chairman of Triporati, Zignal Labs, and LaunchPad Central. He sits on several boards, including KIND Snacks, Revinate, Via.com and One Voice. Jim has taught the Lean LaunchPad and I-Corps courses at UC Berkeley, Stanford, UCSF and Princeton, and is the author of the TED Book “A Haystack Full of Needles.” Jim earned a BA in Economics from Princeton University (Cum Laude), and an MBA from Harvard Business School, where he was a Baker Scholar.

Steve Blank, Founder. Steve has had a 36-year career as a successful entrepreneur and educator. Steve has been a founder or participant in eight Silicon Valley startups. His last startup, E.piphany, was in enterprise software. His other startups include two semiconductor companies (Zilog and MIPS Computers), a workstation company (Convergent Technologies), a supercomputer firm (Ardent), a computer peripheral supplier (SuperMac), a military intelligence systems supplier (ESL) and a video game company (Rocket Science Games). Steve’s book about building early stage companies: Four Steps to the Epiphany launched the Lean Startup movement. His next book, The Startup Owners Manual became the standard handbook for how to start a company. Since 2000, Steve has been part of the entrepreneurship faculty at U.C. Berkeley, Stanford, Columbia University and UCSF. His Lean LaunchPad class, modified for the NSF Innovation Corps and the National Institute of Health, has become the standard for experiential entrepreneurial education.

Steve BlankJim Hornthal

Growcentia’s Board of Advisors

Matt Henn, Ph.D Senior Vice President, Head of Drug Discovery & Bioinformatics Seres Therapeutcs. He is the Senior Vice President and Head of Drug Discovery & Bioinformatics of Seres Therapeutics, Inc. ("Seres"). He has more than 16 years of combined research experience in microbial ecology, genomics, and bioinformatics that spans both environmental and infectious disease applications. Dr. Henn's research has focused on the development, implementation, and application of genomic technologies in the area of microbial populations and their metabolic functions. Prior to joining Seres, he was the Director of Viral Genomics and Assistant Director of the Genome Sequencing Center for Infectious Diseases at the Broad Institute of MIT and Harvard. He has authored over 60 peer-reviewed publications in microbiology and bioinformatics. At Berkeley, he was a NASA Earth Systems Sciences Fellow, and he trained as a NSF Postdoctoral Fellow in microbiology at Duke University.

Jack Gilbert Ph. D is a Group Leader in microbial ecology at Argonne National Laboratory, Associate Director of the Institute for Genomic and Systems Biology and Adjunct Senior Scientist at the Marine Biological Laboratory at the University of Chicago. His research is focused on the ecology, evolution and metabolic dynamics of microbial ecosystems from myriad environments including built environments, oceans, rivers, soils, air, plants, animals and humans. Leveraging next-generation sensor technology, Jack is creating networked grids of automated microbial detection platforms to capture microbial ecosystem dynamics in air and water based environments. These cloud system enabled sensor arrays provide real-time feedback on how environmental changes affect microbial processes to facilitate translational impacts on policy and management decisions. Jack also founded and has led the Earth Microbiome Project (www.earthmicrobiome.org) and American Gut (www.americangut.org), two massive collaborative efforts aimed at developing a comprehensive understanding of the bacterial and fungal communities that inhabit the myriad niches across our planet and in our bodies.

Jack Gilbert Ph.D.Matt Henn Ph.D.

Growcentia’s Board of Advisors

Andy Renz Ph. D is an experienced leader in technology evaluation and business development in the agricultural biotechnology area. Prior to joining Benson Hill Biosystems, he was the head of Technology Scouting and Acquisition Americas at BASF Plant Science. Andy has more than a decade of international experience in business development and is responsible for numerous license, service, collaboration and international consortium agreements in Europe, Asia, North America and South America. Andy studied biology and received his Ph.D. in plant biochemistry and physiology at the University of Bayreuth, Germany, followed by postdoctoral studies in plant molecular biology at the Max Planck Institute of Molecular Plant Physiology in Potsdam, Germany.

Christine Perich, CEO of New Belgium Brewing Company, and a member of the company’s Board of Director. Christine has been an integral part of New Belgium’s growth and success. When she started at New Belgium in 2000, the company operated a 165,000 barrelage production facility and distributed its beers in 7 states. Now, New Belgium produces more than 945,000 barrels and distributes its products in 39 states and in Alberta, British Columbia and Sweden. She received a Bachelor of Science in Business Administration from Colorado State University and is a member of the College of Business Global Leadership Counsel, the Dean’s advisory board for the College of Business. She also serves on the Board of Directors of Health-Ade, an industry-leading producer of kombucha, and is a member of the Brewers Association Finance Committee.

Christine PerichAndy Renz Ph.D.

Growcentia’s Board of Advisors

Greg Owsley Founder of the Storied Brand started getting his first marketing break at a Colorado farm teaching national grocery chains to love their organic vegetables. Then in 1996 he became brand & marketing guy for New Belgium® Brewing and Fat Tire Ale®. When Owsley joined New Belgium it was producing 30K annual barrels of microbrew; at his departure around 750K barrels. Greg was the steward and chief storyteller of the developing brand (including Fat Tire) and had an instrumental hand in New Belgium’s nationally recognized company culture and sustainable business model. His strategy and executions with what is deemed “sustainable branding” earned him multiple keynote speaker roles at green business conferences and a CMO Strategy op-ed in Advertising Age. In June 2011, Greg opened The Storied Brand™. Dedicated to the theory that any brand, with the right authoring, can become iconic. Owsley is loving the opportunity to prove his hypothesis across a broad set of categories with global giants, ambitious start-ups, and local heroes.

Greg Owsley

Scaling Revenue

International Expansion $ 700,000

Adding to Sales Team $ 500,000R & D

Product Development $ 2,500,000

New Crops to Market $ 1,300,000

$ 5.0 M Series A (equity): Use of Proceeds